What factors affect the prognosis of uterine cancer?

There are two types of uterus cancer. The first, also called endometrial cancer, is the uterine lining cancer; This type of uterine cancer is by far the more common of the two. The second type, uterine sarcoma, includes cancer cells in musculature surrounding the female uterus. The prognosis of uterine cancer varies depending on three factors: degree of tumor, cancer stage and cancer reaction to progesterone.

When a physician suspects that the patient may have uterine cancer, the doctor will perform a cervical biopsy that involves removing part of the uterus and sending a laboratory. The technicians then explore this tissue. If a malignant or cancer tumor is present, the technician will evaluate the tumor such as 1, 2 or 3 based on the size and texture of the mass. The prognosis of uterine cancer partly depends on the degree of tumor. For most people who are a well -growing uterine cancer for people with this disease. Uterine cancer 1 means that cancer is present only along Sthe uterus. Phases 1a and 1b indicate the depth of cancer. According to the American Cancer Society, the five -year survival rate is 96 percent at this stage.

Phase 2 means that uterine cancer is in the uterine cervix, which is the closest part of the body to the uterus. In Phase 3, cancer is regionally extended to other parts of the reproductive system, such as ovaries or fallopian tubes or lymph nodes in this part of the body. The last phase of the uterus cancer suggests that the spread of cancer reaches outside the pelvic area or that there is cancer in the bladder in the region. As the presentation proceeds, the level of survival of the uterus cpacienti with Acery decreases.

reaction of tumor to progesterone also affects the prognosis of uterine cancer. The use of progesterone therapy is a way to reduce uterine cancer growth at a late stage. Patients using this therapy receive injections or oral regulations for progesterone, which afterIt can compensate the effects of too large estrogen. Progesterone therapy does not cure uterine cancer; Rather, it works to prolong the life of the patient with the greatest quality of life.